6-bromo-2-oxo-2H-chromene-3-carboxylic acid, 95.0%, 1g

Methyl 3-methyl-1,2,4-oxadiazole-5-carboxylate, 95%, 25g

1-Propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

4-Nitro-N-propylbenzamide, 97%, 1g

8-Bromo-6-chloro-2-methyl-[1,2,4]triazolo[1,5-a]pyridine, 95.0%, 1g

N,2-dimethyl-3-pyrrolidin-1-ylpropan-1-amine, 95.0%, 5g

(R)-3-(Benzhydryloxy)-1-(2-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidine fumarate, 98.0%, 5mg

Methyl(pyridazin-4-ylmethyl)amine hydrochloride, 98+%, 500mg

Squalene, min. 90%, for synthesis, 500 ml, glass packaging

[4-(4-fluorophenyl)piperazin-1-yl](phenyl)acetic acid, 1g

1-cyclopentyl-4-piperidinamine, 95.0%, 5g

3,4-Dihydro-1H-quinoxalin-2-one, 95.0%, 5g

3-Chloro-5-iodobenzaldehyde, 250mg